NEW YORK (GenomeWeb) – PerkinElmer said today that it has inked a definitive agreement to acquire Lübeck, Germany-based Euroimmun Medical Laboratory Diagnostics for about $1.3 billion in cash.

Euroimmun is recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing, and has "extensive expertise and capabilities" across immunology, cell biology, histology, biochemistry, and molecular biology, PerkinElmer said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.